AI-driven cardiac ultrasound analysis” project for better heart ultrasound
Ligence starts implementing a project “AI-driven cardiac ultrasound analysis” which will increase heart ultrasound procedure accessibility, quality of procedure analysis.
Aortic stenosis
Aortic stenosis (AS) is one of the most common acquired heart defects in adults. Echocardiography is a primary diagnostic tool to assess the severity of this pathology. The assessment of aortic stenosis requires complex measurements that take considerable amount of time and should be performed by an expe
Motivational interview?
Is motivational interview a clinical tool?
Yes!
It’s not a job interview, neither it’s a coaching session. It’s a technique to prompt a change in patient’s lifestyle that physicians and nurses could/should use it in their cabinets. Much of health care today involves helping patients manage conditions whose outcomes can be greatly influenced by lifestyle or behaviour change. Motivational interview (MI) is a powerful tool to enhance communication with patients and guide them in making choices to improve their health, from weight loss, exercise, and smoking cessation, to medication adherence. Its effectiveness has been proven by numerous research. MI can last from 15 to 160 minutes, depending on the setting.
Ligence receives Certificate for the Ligence Heart AI system
Ligence Heart analysis and reporting system for transthoracic echocardiography has been certified under MDR 2017/745.
The device is regulated as medical device class IIa under the framework of the European Commission.
The Ligence Heart AI system will be now offered to care centres in Europe to aid with the burdens of the echocardiography procedure.
The company expects first sales to happen in Lithuania and the Baltic region, followed by the Netherlands.
Webinar Digital Cardiology
A moment from a joint webinar “Digital Cardiology” organised by the Lithuanian Cardiology Society and Ligence.
The star guest Eugenio Picano delivered a presentation on what do clinicians want from AI in echocardiography. One of the main missions of AI in echocardiography is to leverage the “hibernating data” from retrospective databases which may open new insights in patient outcomes.
Make sure to follow updates from Lithuanian Cardiology Society and Ligence.
Ligence enrolls in one of the largest Stress Echocardiography studies
We are excited and proud to be working with leading minds in echocardiography to define the future of heart imaging. Ligence is participating in one of the largest echocardiography studies Stress Echo 2030 (SE2030)!
Echo as a prognostic tool in COVID-19
The recent publication in Medscape, an online medical knowledge resource platform for medical professionals, suggests that echocardiography (2D transthoracic echocardiography) is the best practical prognostic measure for in-hospital patient mortality assessment.
Innostars Awards Winner
Ligence has won the Innostars Awards hosted by the European Institute of Innovation and Technology. Ligence is a small startup company with a great idea and a heroic goal that will bring innovative solutions in healthcare.
Lithuanian Startup Museum
Ligence has been chosen to be displayed at the first in the world and first in Lithuania Startup Museum. The initiative is curated by Go Vilnius an agency for tourism and business development in Vilnius city
Echocardiography for COVID-19 Patients
Heart ultrasound might be extremely important to patients tested positive for COVID-19. The disease itself shows very complex pathophysiological mechanisms and may cause a variety of illnesses. Therefore, the examination can benefit patient outcomes in terms of survival and recovery from the disease.